Loading clinical trials...
Loading clinical trials...
Phase I Study of Autologous Mesenchymal Stem Cells in the Treatment of Atherosclerotic Renal Artery Stenosis
Conditions
Interventions
Arterial infusion of autologous mesenchymal stem cells
Locations
1
United States
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Start Date
April 1, 2013
Primary Completion Date
March 1, 2014
Completion Date
April 1, 2017
Last Updated
August 7, 2017
Lead Sponsor
Mayo Clinic
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions